ReviewJournal of ophthalmology2026
Selective Laser Trabeculoplasty Compared to Medication for Open-Angle Glaucoma Patients: A Systematic Review and Meta-Analysis.
Review in Journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Selective Laser Trabeculoplasty Compared to Medication for Open-Angle Glaucoma Patients: A Systematic Review and Meta-Analysis.Journal of ophthalmology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: An alternative glaucoma treatment is selective laser trabeculoplasty (SLT) that can effectively reduce intraocular pressure (IOP) and decrease the burden of glaucoma management. With newly published randomized controlled trials (RCTs) comparing SLT and medication, an updated systematic review and meta-analysis was needed. Methods: A literature search of RCTs comparing SLT and medication in open-angle glaucoma patients was conducted until January 12, 2024 in CINAHL, Cochrane Library, EMBASE, MEDLINE, Web of Science, ClinicalTrials.gov, and Dissertations and Theses databases. Cochrane Risk of Bias 2 (ROB2) was used to assess the quality of the included RCTs. Results: The included 16 RCTs comprised 2412 patients. At 26 weeks, the combination treatment of SLT and medication had a significant IOP reduction (SMD = 0.78, 95% CI = [0.56, 1.01], Conclusion: Long-term IOP reduction was greater in the SLT treatment compared to medication. SLT treatment significantly reduced the number of medications used by participants whereas medication group had no significant change.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.